{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:56:05Z","timestamp":1786978565347,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1006\/exnr.1997.6598","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:00:46Z","timestamp":1033930846000},"page":"123-129","source":"Crossref","is-referenced-by-count":16,"title":["5-Fluorouracil and Levamisole Exacerbate Demyelination in Susceptible Mice Infected with Theiler's Virus"],"prefix":"10.1006","volume":"147","author":[{"given":"C.F.","family":"Lucchinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.W.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pavelko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1997.6598_EN976598RF1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1600-0404.1978.tb04510.x","article-title":"Levamisole in multiple sclerosis with special reference to immunological parameters","volume":"57","author":"Cendrowski","year":"1978","journal-title":"Acta Neurol. Scand."},{"key":"10.1006\/exnr.1997.6598_EN976598RF2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1227\/00006123-199412000-00019","article-title":"Multifocal inflammatory leukoencephalopathy with levamisole and 5-fluorouracil: Case report","volume":"35","author":"Chen","year":"1994","journal-title":"Neurosurgery"},{"key":"10.1006\/exnr.1997.6598_EN976598RF3","first-page":"2529","article-title":"Decreased immunosuppression associated with 5-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouradine","volume":"43","author":"Connolly","year":"1983","journal-title":"Cancer Res."},{"key":"10.1006\/exnr.1997.6598_EN976598RF4","first-page":"302","article-title":"The effect of levamisole on cellular immunity in multiple sclerosis","volume":"26","author":"Dau","year":"1976","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/07357909409038226","article-title":"Cerebral demyelination with 5-fluorouracil and levamisole","volume":"12","author":"Fassas","year":"1994","journal-title":"Cancer Invest."},{"key":"10.1006\/exnr.1997.6598_EN976598RF6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00313411","article-title":"Modulation of immunity in multiple sclerosis. A double blind levamisole placebo-controlled study in 85 patients","volume":"228","author":"Gonsette","year":"1982","journal-title":"J. Neurol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/IAI.41.3.1157-1165.1983","article-title":"Levamisole exacerbates Coxsackievirus B3-induced murine myocarditis","volume":"41","author":"Gudvangen","year":"1983","journal-title":"Infect. Immun."},{"key":"10.1006\/exnr.1997.6598_EN976598RF8","series-title":"Immunopathology","article-title":"Mechanism of immunopotentiation","author":"Hadden","year":"1977"},{"key":"10.1006\/exnr.1997.6598_EN976598RF9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ana.410310306","article-title":"Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole","volume":"31","author":"Hook","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0025-6196(12)60132-3","article-title":"Multifocal leukoencephalopathy occurring during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy","volume":"68","author":"Kimmel","year":"1993","journal-title":"Mayo Clin. Proc."},{"key":"10.1006\/exnr.1997.6598_EN976598RF11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1212\/WNL.45.2.374","article-title":"Multifocal leukoencephalopathy associated with levamisole therapy","volume":"45","author":"Kimmel","year":"1995","journal-title":"Neurology"},{"key":"10.1006\/exnr.1997.6598_EN976598RF12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archneur.1970.00480260061008","article-title":"Biochemical basis for fluorouracil neurotoxicity: The role of Krebs cycle inhibition by fluoro-acetate","volume":"23","author":"Koenig","year":"1970","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF13","series-title":"Concepts in Viral Pathogenesis","first-page":"260","article-title":"Virus-induced demyelination","author":"Lampert","year":"1984"},{"key":"10.1006\/exnr.1997.6598_EN976598RF14","unstructured":"B. W. Langley, 1973, Blood Levels with 1-Tetramisole"},{"key":"10.1006\/exnr.1997.6598_EN976598RF15","first-page":"198","article-title":"Symptomatic, radiologic, and pathologic changes in the central nervous system associated with 5-fluorouracil (5-FU) and levamisole (LE) therapy","volume":"12","author":"Leichman","year":"1993","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF16","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0140-6736(04)70094-X","article-title":"Multifocal leukoencephalopathy induced by levamisole","volume":"348","author":"Lucia","year":"1996","journal-title":"Lancet"},{"key":"10.1006\/exnr.1997.6598_EN976598RF17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(80)92107-8","article-title":"Double-blind controlled trial of immunosuppression in treatment of multiple sclerosis","volume":"2","author":"Mertin","year":"1980","journal-title":"Lancet"},{"key":"10.1006\/exnr.1997.6598_EN976598RF18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199002083220602","article-title":"Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma","volume":"322","author":"Moertel","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.1997.6598_EN976598RF19","first-page":"70","article-title":"Multifocal inflammatory leukoencephalopathy caused by adjuvant therapy with 5-fluorouracil and levamisole after resection for adenocarcinoma of the colon (letter)","volume":"87","author":"Neur","year":"1993","journal-title":"Acta Neurol. Scand."},{"key":"10.1006\/exnr.1997.6598_EN976598RF20","first-page":"1379","article-title":"Multifocal leukoencephalopathy following adjuvant therapy with 5-fluorouracil and levamisole (letter)","volume":"117","author":"Neur","year":"1992","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1006\/exnr.1997.6598_EN976598RF21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00687342","article-title":"Neuropathologic study on 5-fluorouracil and its masked compounds in dogs","volume":"63","author":"Okeda","year":"1984","journal-title":"Acta Neuropathol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF22","first-page":"281","article-title":"Differential pathogenesis between mouse strains resistant and susceptible to Theiler's virus-induced demyelination","volume":"1","author":"Patick","year":"1990","journal-title":"Semin. Virol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF23","first-page":"2052","article-title":"Fluorouracil biochemistry and pharmacology","volume":"9","author":"Pinedo","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF24","first-page":"961","article-title":"Acute cerebellar syndrome secondary to 5-fluorouracil therapy","volume":"14","author":"Riehl","year":"1970","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1084\/jem.163.3.620","article-title":"Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region","volume":"163","author":"Rodriguez","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1006\/exnr.1997.6598_EN976598RF26","unstructured":"M. Rodriguez, E. Olesck, J. Leibowitz, Theiler's murine encephalomyelitis virus. A model of demyelination and virus persistence, CRC Crit. Rev. Immunol. 7, 325, 366"},{"key":"10.1006\/exnr.1997.6598_EN976598RF27","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.157.12.5699","article-title":"The balance between persistent virus infection and immune cells determines demyelination","volume":"157","author":"Rodriguez","year":"1996","journal-title":"J. Immunol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/13550289509111015","article-title":"H-2d transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice","volume":"1","author":"Rodriguez","year":"1995","journal-title":"J. Neurovirol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF29","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.4049\/jimmunol.140.9.2950","article-title":"Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-lyt-2 antibody","volume":"140","author":"Rodriguez","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF30","first-page":"9","volume":"40","author":"Silverberg","year":"1990","journal-title":"Cancer Statistics"},{"key":"10.1006\/exnr.1997.6598_EN976598RF31","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.1991.9.11.2052","article-title":"Levamisole: Known effects on the immune system, clinical results, and future applications to the treatment of cancer","volume":"9","author":"Stevenson","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/exnr.1997.6598_EN976598RF32","first-page":"163","article-title":"The effect of levamisole on the canine central nervous system","volume":"37","author":"Vanevelde","year":"1978","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488697965985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488697965985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:52:14Z","timestamp":1680609134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488697965985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["S0014488697965985"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1997.6598","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}